{"filings":[{"id":2272276,"accession_number":"0001193125-26-352388","cik":2130606,"company_name":"Gazelle Parent, Inc.","ticker":"OBX","form_type":"8-K/A","filed_at":"2026-08-14T20:29:52+00:00","items":["9.01"],"status":"ready","headline":"Obsidian completes merger with Galera, closes $350M PIPE; H1 net loss $45.5M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger closed July 31, 2026; Obsidian and Galera now subsidiaries of Gazelle Parent, Inc.","Concurrent PIPE financing raised ~$350M gross proceeds, funding operations for next 12 months.","H1 2026 net loss $45.5M; R&D expenses $37.3M, down from $44.1M YoY.","Cash, equivalents, and marketable securities $34.4M at June 30, 2026 (pre-PIPE).","Lead candidate OBX-115 in Phase 2 for melanoma and Phase 1 for NSCLC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":null,"market_cap_as_of_date":null,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2026516,"accession_number":"0001193125-26-330810","cik":2130606,"company_name":"Gazelle Parent, Inc.","ticker":"OBX","form_type":"8-K","filed_at":"2026-08-03T21:08:10+00:00","items":["1.01","2.01","2.02","3.02","3.03","4.01","5.01","5.02","5.03","7.01","9.01"],"status":"ready","headline":"Obsidian Therapeutics completes reverse merger with Legacy Obsidian and Galera; begins trading on Nasdaq under OBX","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Mergers closed Aug 3, 2026; Legacy Obsidian shareholders received 0.1383 shares of Parent per share; Legacy Galera shareholders received 0.7019 shares per share.","Concurrent PIPE of $350M from qualified investors; post-merger ownership: Legacy Obsidian ~51.6%, PIPE investors ~47.2%, Legacy Galera ~1.2%.","New board of six directors appointed, led by Chairperson Maria Fardis; includes CEO Madan Jagasia and other Legacy Obsidian designees.","Galera shareholders receive CVRs for 80% of net proceeds from Legacy Product (5 years) and 95% from Supportive-Care Product Divestiture (10 years).","KPMG appointed as independent auditor; Parent Common Stock to trade on Nasdaq under ticker OBX starting Aug 4, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":null,"market_cap_as_of_date":null,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}